These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 640733)
21. Humoral and cellular immune responses following vaccination with purified recombinant hemagglutinin from influenza A (H3N2) virus. Powers DC; McElhaney JE; Florendo OA; Manning MC; Upshaw CM; Bentley DW; Wilkinson BE J Infect Dis; 1997 Feb; 175(2):342-51. PubMed ID: 9203655 [TBL] [Abstract][Full Text] [Related]
22. Neutralizing Antibody Responses to Homologous and Heterologous H1 and H3 Influenza A Strains After Vaccination With Inactivated Trivalent Influenza Vaccine Vary With Age and Prior-year Vaccination. Wang W; Chen Q; Ford-Siltz LA; Katzelnick LC; Parra GI; Song HS; Vassell R; Weiss CD Clin Infect Dis; 2019 May; 68(12):2067-2078. PubMed ID: 30256912 [TBL] [Abstract][Full Text] [Related]
23. Assessment of immunity to influenza using artifical challenge of normal volunteers with influenza virus. Couch RB Dev Biol Stand; 1975; 28():295-306. PubMed ID: 1126573 [TBL] [Abstract][Full Text] [Related]
24. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge. Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689 [TBL] [Abstract][Full Text] [Related]
26. Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine. Potter CW; Jennings R; Phair JP; Clarke A; Stuart-Harris CH J Infect Dis; 1977 Mar; 135(3):423-31. PubMed ID: 850080 [TBL] [Abstract][Full Text] [Related]
27. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection. Monto AS; Petrie JG; Cross RT; Johnson E; Liu M; Zhong W; Levine M; Katz JM; Ohmit SE J Infect Dis; 2015 Oct; 212(8):1191-9. PubMed ID: 25858957 [TBL] [Abstract][Full Text] [Related]
28. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers. Desheva YA; Smolonogina TA; Donina SA; Rudenko LG BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers. Snyder MH; Clements ML; Betts RF; Dolin R; Buckler-White AJ; Tierney EL; Murphy BR J Clin Microbiol; 1986 May; 23(5):852-7. PubMed ID: 3711273 [TBL] [Abstract][Full Text] [Related]
30. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity. Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910 [TBL] [Abstract][Full Text] [Related]
31. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies. Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855 [TBL] [Abstract][Full Text] [Related]
32. Antibody response to influenza vaccination in healthy adults. Brydak LB; Tadeusz S; Magdalena M Viral Immunol; 2004; 17(4):609-15. PubMed ID: 15671759 [TBL] [Abstract][Full Text] [Related]
33. Seasonal influenza vaccination is the strongest correlate of cross-reactive antibody responses in migratory bird handlers. Oshansky CM; Wong SS; Jeevan T; Smallwood HS; Webby RJ; Shafir SC; Thomas PG mBio; 2014 Dec; 5(6):e02107. PubMed ID: 25491354 [TBL] [Abstract][Full Text] [Related]
34. Enzyme immunoassay, complement fixation and hemagglutination inhibition tests in the diagnosis of influenza A and B virus infections. Purified hemagglutinin in subtype-specific diagnosis. Julkunen I; Pyhälä R; Hovi T J Virol Methods; 1985 Jan; 10(1):75-84. PubMed ID: 3882733 [TBL] [Abstract][Full Text] [Related]
35. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination]. Stumpa A; Tůmová B Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986 [No Abstract] [Full Text] [Related]
36. Hemagglutinin-specific CD4 Tan S; Zhang S; Wu B; Zhao Y; Zhang W; Han M; Wu Y; Shi G; Liu Y; Yan J; Wu G; Wang H; Gao GF; Zhu F; Liu WJ Vaccine; 2017 Oct; 35(42):5644-5652. PubMed ID: 28917539 [TBL] [Abstract][Full Text] [Related]
37. Inactivated Antigen of the H7N9 Influenza Virus Protects Mice from Its Lethal Infection. Seo SH; Kim HS Viral Immunol; 2016 May; 29(4):235-43. PubMed ID: 26910526 [TBL] [Abstract][Full Text] [Related]
38. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype. Walz L; Kays SK; Zimmer G; von Messling V J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654 [TBL] [Abstract][Full Text] [Related]
39. [Antineuraminidase serum antibodies in natural influenza A and immunization with influenza vaccines]. Naĭkhin AN; Tsaritsyna IM; Syrodoeva LG; Oleĭnikova EV; Gorev NE Vopr Virusol; 1983; (2):154-9. PubMed ID: 6868553 [TBL] [Abstract][Full Text] [Related]